Gonyer David A

President and CEO at Evoke Pharma Inc

Sold, on record
$210k
Dollars the filings state
Form 4 sales
1
Latest Dec 14, 2020
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Dec 14, 2020Plan not stated

    Evoke Pharma Inc

    Sold 17.5% of their holdings

    $210k72,000 shares at $2.91

    Filed Dec 14, 2020Form 4

1 of 1

Every transaction

Every transaction on a Form 4 or Form 5 by Gonyer David A
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Feb 8, 2023Feb 10, 2023Evoke Pharma IncCEOAwardedStock Option (Right to Buy)30,00030,000SEC
Feb 2, 2022Feb 4, 2022Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)175,000175,000SEC
Jan 27, 2021Jan 29, 2021Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)415,000415,000SEC
Dec 14, 2020Dec 14, 2020Evoke Pharma IncPresident and CEOSold72,000$2.91$210k339,782SEC
Dec 9, 2020Dec 11, 2020Evoke Pharma IncPresident and CEOExercised or settledStock Option (Right to Buy)72,0000SEC
Dec 9, 2020Dec 11, 2020Evoke Pharma IncPresident and CEOExercised options72,000$0.40$29k411,782SEC
Sep 1, 2020Sep 2, 2020Evoke Pharma IncPresident and CEOOther20,238$1.05$21k339,782SEC
Feb 28, 2020Mar 3, 2020Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)325,000325,000SEC
Jun 17, 2019Jun 19, 2019Evoke Pharma IncPresident and CEOReturned to the companyStock Option (Right to Buy)890,6870SEC
Jun 17, 2019Jun 19, 2019Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)668,015168,750SEC
Feb 6, 2019Feb 8, 2019Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)225,000225,000SEC
Aug 31, 2018Sep 5, 2018Evoke Pharma IncPresident and CEOOther6,901$1.63$11k319,544SEC
Apr 26, 2018Apr 27, 2018Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)225,000225,000SEC
Aug 31, 2017Sep 5, 2017Evoke Pharma IncPresident and CEOOther8,240$2.15$18k312,643SEC
Feb 28, 2017Mar 2, 2017Evoke Pharma IncPresident and CEOOther12,000$1.60$19k304,403SEC
Feb 8, 2017Feb 8, 2017VRDNDirectorExercised or settledStock Option (Right to Buy)1,2000SEC
Feb 8, 2017Feb 8, 2017VRDNDirectorExercised options1,200$7.65$9k1,899SEC
Jan 25, 2017Jan 27, 2017Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)225,000225,000SEC
Jun 15, 2016Jun 20, 2016VRDNDirectorAwardedStock Option (Right to Buy)18,00018,000SEC
Mar 1, 2016Mar 1, 2016Evoke Pharma IncPresident and CEOOther4,669$2.90$14k292,403SEC
Feb 5, 2016Feb 5, 2016Evoke Pharma IncPresident and CEOReturned to the companyStock Option (Right to Buy)174,2500SEC
Feb 5, 2016Feb 5, 2016Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)130,68760,000SEC
Jan 28, 2016Jan 29, 2016Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)85,00085,000SEC
Aug 31, 2015Sep 2, 2015Evoke Pharma IncPresident and CEOOther4,023$3.31$13k287,734SEC
Aug 6, 2015Aug 10, 2015VRDNDirectorExercised or settledRestricted Stock Units4,1250SEC
Aug 6, 2015Aug 10, 2015VRDNDirectorExercised options4,1255,500SEC
Aug 6, 2015Aug 10, 2015VRDNDirectorAwardedStock Option (Right to Buy)18,00018,000SEC
Aug 6, 2015Aug 10, 2015VRDNDirectorAwarded5,00010,500SEC
Jul 17, 2015Jul 21, 2015VRDNDirectorExercised or settledRestricted Stock Units1,3754,125SEC
Jul 17, 2015Jul 21, 2015VRDNDirectorExercised options1,3751,375SEC
Mar 6, 2015Mar 9, 2015Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)80,00080,000SEC
Feb 27, 2015Mar 2, 2015Evoke Pharma IncPresident and CEOOther2,711$4.75$13k283,711SEC
Jul 17, 2014Jul 21, 2014VRDNDirectorAwardedStock Option (right to buy)11,5005,500SEC
Mar 31, 2014Feb 6, 2015Evoke Pharma IncPresident and CEOOther164,000281,000SEC
Mar 31, 2014Feb 6, 2015Evoke Pharma IncPresident and CEOOther164,000281,000SEC
Dec 2, 2013Dec 3, 2013Evoke Pharma IncPresident and CEOAwardedStock Option (Right to Buy)94,25094,250SEC

Sales and notices (1)

Form 144 notices and Form 4 sales by Gonyer David A
Source
Dec 14, 2020Dec 14, 2020Evoke Pharma IncPresident and CEOForm 4 sale72,000$210k17.5%Plan not statedSEC